Etoposide, Cyclophosphamide, Thalidomide, Celecoxib, and Fenofibrate in Relapsed or Progressive Cancer

Clinical trial NCT00357500 · COMPLETED

Trial details

NCT number: NCT00357500
Sponsor: Dana-Farber Cancer Institute
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Central Nervous System Tumor, Pediatric Leukemia Lymphoma Neuroblastoma Sarcoma Unspecified Childhood Solid Tumor, Protocol Specific

Start date: 2005-01-01
Primary completion: 2013-02-01
Enrollment: 101

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.